CN114129142A - Treatment evaluation method - Google Patents

Treatment evaluation method Download PDF

Info

Publication number
CN114129142A
CN114129142A CN202111256433.XA CN202111256433A CN114129142A CN 114129142 A CN114129142 A CN 114129142A CN 202111256433 A CN202111256433 A CN 202111256433A CN 114129142 A CN114129142 A CN 114129142A
Authority
CN
China
Prior art keywords
patient
blood pressure
treatment
test
self
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111256433.XA
Other languages
Chinese (zh)
Inventor
何丽红
赵婧
张春国
颜华英
王泓力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Provincial Hospital for Women and Children
Original Assignee
Sichuan Provincial Hospital for Women and Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Provincial Hospital for Women and Children filed Critical Sichuan Provincial Hospital for Women and Children
Priority to CN202111256433.XA priority Critical patent/CN114129142A/en
Publication of CN114129142A publication Critical patent/CN114129142A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4836Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery

Abstract

The invention discloses a treatment evaluation method, which relates to the technical field of medical evaluation and comprises the following steps: s1, obtaining blood pressure values of multiple volunteers with determined absence of hypertension as horizontal reference value A by sphygmomanometer measurement0(ii) a S2, performing blood pressure self-test at frequency of three times per day in one week after discharge of hypertension patient, and recording time of good test and test value An(ii) a S3, arranging all the data measured in S2 according to the steps from small to large, and then calculating the median X of the datan(ii) a S4, calculating the median X in S3nWith a horizontal reference value A0And comparing, judging the actual treatment effect of the patient, and issuing a corresponding treatment scheme and a medicine adjustment scheme. The method can reduce the influence of additional factors on the treatment evaluation of the patient, simultaneously can abandon the extreme measurement value of the patient within a period of time, and is favorable for better reflecting the actual condition of the patientThe method is described.

Description

Treatment evaluation method
Technical Field
The invention relates to the technical field of medical evaluation, in particular to a treatment evaluation method.
Background
Hypertension is a clinical syndrome characterized by an increase in systemic arterial blood pressure (systolic pressure and/or diastolic pressure) and may be accompanied by functional or organic impairment of organs such as heart, brain, and kidney. Hypertension is the most common chronic disease and also the most major risk factor for cardiovascular and cerebrovascular diseases. The blood pressure of a normal person fluctuates within a certain range along with the changes of internal and external environments. In the whole population, the blood pressure level gradually increases with age, the systolic pressure is more obvious, but the diastolic pressure shows a descending trend after the age of 50, and the pulse pressure is increased. In recent years, people have increasingly deep knowledge on the effects of multiple risk factors of cardiovascular diseases and the protection of target organs of heart, brain and kidney, the diagnosis standard of hypertension is continuously adjusted, and at present, patients with the same blood pressure level are considered to have different cardiovascular disease risks, so that the concept of blood pressure stratification is provided, namely, the patients with different cardiovascular disease risks are different in proper blood pressure level.
The main hypertension group is the middle-aged and old people group, is the genuine invisible killer, with people's deepening to the degree of attention of healthy, and medical development, hypertension crowd can control blood pressure in a stable scope through the medicine now, the standard of judging to hypertension of hospital all is through the standard that Chinese hypertension treatment guideline in 2005 now, because the difference of personnel's physique and habits and customs in different areas, probably lead to actual aassessment to the deviation, and single testing result also does not have the representativeness, can not be fine reaction patient's actual blood pressure condition.
Disclosure of Invention
The invention aims to solve the problems that in the prior art, deviation can occur in actual evaluation due to differences of constitutions and living habits of people in different regions, single detection results are not representative, and actual blood pressure conditions of patients cannot be reflected well.
In order to achieve the purpose, the invention adopts the following technical scheme:
a method of therapy assessment comprising the steps of:
s1, obtaining blood pressure values of multiple volunteers with determined absence of hypertension as horizontal reference value A by sphygmomanometer measurement0
S2, performing blood pressure self-test at frequency of three times per day in one week after discharge of hypertension patient, and recording time of good test and test value An
S3, arranging all the data measured in S2 according to the steps from small to large, and then calculating the median X of the datan
S4, calculating the median X in S3nWith a horizontal reference value A0And comparing, judging the actual treatment effect of the patient, and issuing a corresponding treatment scheme and a medicine adjustment scheme.
Preferably, the plurality of volunteers should be in a plurality of age groups and need to have volunteers with different sexes, and the volunteers with different sexes are divided into two groups according to male and female, and measured in a small group at intervals of five years, thereby obtaining the horizontal reference value A0
Preferably, the patient's frequency of self-tests per day may be three times per day or once every five hours.
Preferably, the patient's self-test time is preferably measured first in the morning on an empty stomach, second two hours after lunch and third one hour before bedtime.
Preferably, care should be taken to maintain a seated position during the patient's self-test, and no vigorous movement should be taken within the first two hours of the test.
Preferably, the patient self-tests using an electronic sphygmomanometer, and also requests the doctor to perform blood pressure measurement through the hospital.
Preferably, in the measurement result obtained by the self-test, a group of measurement values A are obtained after being arranged from large to small1A2A3……AnAccording to the formula Xn=A(n+1)/2The median was obtained.
Preferably, according to the median number XnWith a horizontal reference value A0When the comparison of (2) is carried out for result evaluation;
when X is presentn>A0+5, indicating that the blood pressure of the patient is higher than normal after treatment and requiring drugs to assist the patient in blood pressure control;
when A is0-5<Xn<A0+5, indicating that the blood pressure of the patient is at a normal level after treatment, the medication can be properly reduced or the medication can be stopped temporarily;
when X is presentn<A0And 5, indicating that the blood pressure of the patient is lower than a normal level after treatment, and stopping taking medicine immediately and paying close attention to the change of the blood pressure.
Preferably, when patient self-test data is aligned with horizontal reference data, the patient should be aligned with volunteer data of the same sex and age group.
Preferably, at the time of data analysis, the patient should be asked for past medical history and focused on whether the patient smokes, whether the abdomen is obese, and the like.
Compared with the prior art, the invention has the following advantages:
according to the invention, by collecting the median of the change condition of the blood pressure of the patient in one week and comparing the change condition with the blood pressure state of volunteers with the same age range and the same sex in the area, the influence of additional factors on the treatment evaluation of the patient is reduced, extreme measurement values of the patient within a period of time can be abandoned, the actual condition of the patient can be better reflected, a doctor can accurately evaluate the patient conveniently, and the problems that the actual evaluation is deviated due to the difference of the physique and the living habit of personnel in different areas in the prior art, and the single detection result is not representative and cannot well reflect the actual blood pressure condition of the patient are solved.
Detailed Description
A method of therapy assessment comprising the steps of:
s1, obtaining blood pressure values of multiple volunteers with determined absence of hypertension as horizontal reference value A by sphygmomanometer measurement0By searching volunteers in the same region, the variable factors possibly existing between the volunteers and the patient can be reduced as much as possible,to improve the accuracy of treatment assessment.
The volunteers are required to be in multiple age groups and have different sexes, the volunteers with different sexes are divided into two groups according to male and female, when different patients are compared, the gender is firstly distinguished, data deviation caused by gender factors is avoided, the volunteers are divided into one group at intervals of five years for measurement, in order to reduce the data volume deviation caused by age, the age sections of the thinned volunteers are distinguished as much as possible, and therefore the horizontal reference value A is obtained0
S2, in the period of one week after the discharge of the hypertensive, the blood pressure may be reduced for a short time due to the treatment and drug control of the patient in the hospital, but the discharge may cause the blood pressure to rise again due to the lack of scientific health guidance before the patient resumes work, and the aunt may arouse the attention of the patient and the doctor, need to perform self-test after the discharge for subsequent evaluation, perform the self-test of the blood pressure at a frequency of three times a day, and record the time of the test and the test value An
The patient can measure the blood pressure value of the patient at different time periods every day, wherein the patient can measure the blood pressure value three times every day or once every five hours, so as to know the actual blood pressure condition of the patient more accurately.
The self-testing time of the patient is preferably the first time of measurement in the morning on an empty stomach, the second time of measurement two hours after lunch and the third time of measurement one hour before sleeping, which is favorable for accurately measuring the blood pressure and avoids the influence of diet on the blood pressure.
Wherein, in the process of patient's self-test, should pay attention to keep the position of sitting, the position of sitting is favorable to the vehicle of blood pressure more, and should not violently move in measuring the first two hours, avoids the blood pressure rise that the motion leads to, easily causes the inaccuracy of data.
When a patient performs self-measurement, the electronic sphygmomanometer can be used for self-measurement, and a doctor can be requested to perform blood pressure measurement through a hospital.
S3, arranging all the data measured in S2 according to the steps from small to large, and then calculating the median X of the datanThe median can more accurately reflect the median of a group of data, reduce the influence of extreme values on the whole group of data, and avoid the influence of some inaccurate data on the whole group of measured data by self-test of patients.
Wherein, in the measurement result obtained by self-test, a group of measurement values A are obtained after being arranged from large to small1A2A3……AnAccording to the formula Xn=A(n+1)/2Obtaining median, if the number of the measured data is even number, selecting two middle numbers, and taking the average number to obtain Xn
S4, calculating the median X in S3nWith a horizontal reference value A0And comparing, judging the actual treatment effect of the patient, and issuing a corresponding treatment scheme and a medicine adjustment scheme.
Wherein, according to the median XnWith a horizontal reference value A0When the comparison of (2) is carried out for result evaluation;
when X is presentn>A0+5, indicating that the blood pressure of the patient is higher than normal after treatment and requiring drugs to assist the patient in blood pressure control;
when A is0-5<Xn<A0+5, indicating that the blood pressure of the patient is at a normal level after treatment, the medication can be properly reduced or the medication can be stopped temporarily;
when X is presentn<A05, indicating that the blood pressure of the patient is lower than the normal level after treatment, stopping the medicine immediately and paying close attention to the change of the blood pressure, and knowing the actual condition of the patient through comparison and clearance so as to conveniently and accurately evaluate the state of the patient and perform proper medicine adjustment on the patient.
Wherein, when the patient self-test data is compared with the horizontal reference data, the patient should be compared with the data of volunteers in the same sex and age group.
In the data analysis, the past medical history of the patient should be inquired, and the factors of whether the patient smokes, whether the abdomen is fat, and the like should be paid attention to.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.

Claims (10)

1. A method of therapy assessment comprising the steps of:
s1, obtaining blood pressure values of multiple volunteers with determined absence of hypertension as horizontal reference value A by sphygmomanometer measurement0
S2, performing blood pressure self-test at frequency of three times per day in one week after discharge of hypertension patient, and recording time of good test and test value An
S3, arranging all the data measured in S2 according to the steps from small to large, and then calculating the median X of the datan
S4, calculating the median X in S3nWith a horizontal reference value A0And comparing, judging the actual treatment effect of the patient, and issuing a corresponding treatment scheme and a medicine adjustment scheme.
2. The method of claim 1, wherein the volunteers are of different ages and need to have volunteers with different sexes, and the volunteers with different sexes are divided into two groups according to male and female, and measured in a group separated by five years to obtain the level reference A0
3. A method of treatment assessment according to claim 1, wherein the patient's self-test frequency may be measured three times a day or once every five hours.
4. A treatment assessment method according to claim 3, wherein the patient's self-test time is preferably measured first in the morning on an empty stomach, second two hours after lunch and third one hour before sleep.
5. A treatment assessment method according to claim 1, wherein during the patient's self-test, care should be taken to maintain a sitting position and no vigorous movements should be made within the two hours prior to the test.
6. A treatment assessment method according to claim 1, wherein the patient self-tests either with an electronic sphygmomanometer or by requesting a doctor from the hospital.
7. A treatment assessment method according to claim 1, characterized in that in the self-test measurements, after being arranged in descending order, a set of measurements a is obtained1A2A3……AnAccording to the formula Xn=A(n+1)/2The median was obtained.
8. A method of treatment assessment according to claim 1, wherein the median X is used as the basisnWith a horizontal reference value A0When the comparison of (2) is carried out for result evaluation;
when X is presentn>A0+5, indicating that the blood pressure of the patient is higher than normal after treatment and requiring drugs to assist the patient in blood pressure control;
when A is0-5<Xn<A0+5, indicating that the blood pressure of the patient is at a normal level after treatment, the medication can be properly reduced or the medication can be stopped temporarily;
when X is presentn<A0And 5, indicating that the blood pressure of the patient is lower than a normal level after treatment, and stopping taking medicine immediately and paying close attention to the change of the blood pressure.
9. A method of treatment assessment according to claim 1, wherein when patient self-test data is compared to horizontal reference data, the patient is compared to volunteer data of the same sex and age group.
10. A treatment assessment method according to claim 1, wherein the patient should be asked for past medical history at the time of data analysis, and the patient should be concerned about whether they smoke, whether they are obese or not.
CN202111256433.XA 2021-10-27 2021-10-27 Treatment evaluation method Pending CN114129142A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111256433.XA CN114129142A (en) 2021-10-27 2021-10-27 Treatment evaluation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111256433.XA CN114129142A (en) 2021-10-27 2021-10-27 Treatment evaluation method

Publications (1)

Publication Number Publication Date
CN114129142A true CN114129142A (en) 2022-03-04

Family

ID=80394673

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111256433.XA Pending CN114129142A (en) 2021-10-27 2021-10-27 Treatment evaluation method

Country Status (1)

Country Link
CN (1) CN114129142A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002095641A (en) * 2000-09-26 2002-04-02 Japan Science & Technology Corp Method of supporting clinical treatment and clinical trial and recording medium to record supporting program
US20120143070A1 (en) * 2009-06-30 2012-06-07 Yiming Yao Blood pressure detection method and an apparatus therefor
CN102715896A (en) * 2012-06-28 2012-10-10 鹿得医疗器械(南通)有限公司 Electronic sphygmomanometer with blood pressure data analysis and management functions
CN105447334A (en) * 2016-01-08 2016-03-30 重庆大学 Hypertension diagnosing, treating and managing system based on Android platform
CN106845113A (en) * 2017-01-22 2017-06-13 贵阳康康慢病互联网医院有限公司 A kind of chronic disease method for remote management and its management system based on monitoring of blood pressure

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002095641A (en) * 2000-09-26 2002-04-02 Japan Science & Technology Corp Method of supporting clinical treatment and clinical trial and recording medium to record supporting program
US20120143070A1 (en) * 2009-06-30 2012-06-07 Yiming Yao Blood pressure detection method and an apparatus therefor
CN102715896A (en) * 2012-06-28 2012-10-10 鹿得医疗器械(南通)有限公司 Electronic sphygmomanometer with blood pressure data analysis and management functions
CN105447334A (en) * 2016-01-08 2016-03-30 重庆大学 Hypertension diagnosing, treating and managing system based on Android platform
CN106845113A (en) * 2017-01-22 2017-06-13 贵阳康康慢病互联网医院有限公司 A kind of chronic disease method for remote management and its management system based on monitoring of blood pressure

Similar Documents

Publication Publication Date Title
US9026202B2 (en) Cardiac performance monitoring system for use with mobile communications devices
US10216905B2 (en) Health state trends for a consistent patient situation
US20080294021A1 (en) System and Method for the Management or Control of Cardiovascular Related Diseases, Such as Hypertension
US20040148140A1 (en) Patient condition display
US20040133079A1 (en) System and method for predicting patient health within a patient management system
KR101674997B1 (en) Wearable Apparatus, Server, System, and Method for Extracting Parameters of Cardiovascular
US9402597B1 (en) Mobile vascular health evaluation processes
WO2019166613A1 (en) Methods and systems for measuring a stress indicator, and for determining a level of stress in an individual
Head et al. Ambulatory blood pressure monitoring
CN110786865A (en) System and method for controlling blood glucose using personalized histograms
Ring et al. Cardiac stimulus intensity and heartbeat detection: Effects of tilt‐induced changes in stroke volume
Hofmann et al. A novel smartphone app for blood pressure measurement: a proof-of-concept study against an arterial catheter
Gibbons et al. The evaluation of small fiber function—autonomic and quantitative sensory testing
Schell et al. Forearm and upper-arm oscillometric blood pressure comparison in acutely III adults
CN114129142A (en) Treatment evaluation method
KR20190117205A (en) Method and apparatus for measuring pain depth using photoplethysmograph
Johnson Using cluster analysis to develop a healing typology in vascular ulcers
Radic et al. MEDICATION ADHERENCE AND GENDER DIFFERENCE IN HYPERTENSIVE PATIENTS
Koutsaki et al. [PP. 16.24] INFLUENCE OF STRESS AND ANXIETY ON BLOOD PRESSURE LEVELS IN PATIENTS UNDERGOING ORTHOPEDIC SURGERY
Abdelkarim et al. Effect of Body Position Change on Blood Pressure Readings from Both Arms
RU2543293C2 (en) Individual&#39;s physiological parameters control device
RU2694262C1 (en) Method of treating compensated and decompensated disturbed cardiac hemodynamic in acute verapamil poisoning
Yamasue et al. PS-C07-5: ASSOCIATION OF OVERNIGHT URINARY INDICATORS AND BMI WITH NIGHT TIME AND DAYTIME BLOOD PRESSURE IN ELDERLY
Sovic et al. CLINICAL INERTIA AND ADHERENCE IN THE CROATIAN RURAL AREA DAMAGED BY AN EARTHQUAKE.“THE SILENT KILLER HUNT”-CROATIAN SOCIETY OF HYPERTENSION PROJECT
Karim et al. THERAPEUTIC COMPLIANCE IN HYPERTENSIVE PATIENTS: A CROSS SECTIONAL STUDY

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination